Aspirin for primary prevention of cardiovascular events in diabetes: still an open question
- PMID: 18997199
- DOI: 10.1001/jama.2008.625
Aspirin for primary prevention of cardiovascular events in diabetes: still an open question
Comment on
-
Low-dose aspirin for primary prevention of atherosclerotic events in patients with type 2 diabetes: a randomized controlled trial.JAMA. 2008 Nov 12;300(18):2134-41. doi: 10.1001/jama.2008.623. Epub 2008 Nov 9. JAMA. 2008. PMID: 18997198 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical